Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002073638 | SCV002380425 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2021-05-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004729074 | SCV005336622 | uncertain significance | JAG1-related disorder | 2024-06-25 | no assertion criteria provided | clinical testing | The JAG1 c.1121-14_1121-10del5 variant is predicted to result in an intronic deletion. This variant is predicted to interfere with splicing at the consensus acceptor site based on splicing prediction programs (SpliceAI, Jaganathan K, et al. 2019. PubMed ID: 30661751). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |